Meijer L, Azzi L, Wang J Y
CNRS, Station Biologique, Roscoff, France.
EMBO J. 1991 Jun;10(6):1545-54. doi: 10.1002/j.1460-2075.1991.tb07674.x.
A universal intracellular factor, the 'M phase-promoting factor' (MPF), triggers the G2/M transition of the cell cycle in all organisms. In late G2, it is present as an inactive complex of tyrosine-phosphorylated p34cdc2 and unphosphorylated cyclin Bcdc13. In M phase, its activation as an active MPF displaying histone H1 kinase (H1K) originates from the concomitant tyrosine dephosphorylation of the p34cdc2 subunit and the phosphorylation of the cylin Bcdc13 subunit. We have investigated the role of cyclin in the formation of this complex and the tyrosine phosphorylation of p34cdc2, using highly synchronous mitotic sea urchin eggs as a model. As cells leave the S phase and enter the G2 phase, a massive tyrosine phosphorylation of p34cdc2 occurs. This large p34cdc2 tyrosine phosphorylation burst does not arise from a massive increase in p34cdc2 concentration. It even appears to affect only a fraction (non-immunoprecipitable by anti-PSTAIR antibodies) of the total p34cdc2 present in the cell. Several observations point to an extremely close association between accumulation of unphosphorylated cyclin and p34cdc2 tyrosine phosphorylation: (i) both events coincide perfectly during the G2 phase; (ii) both tyrosine-phosphorylated p34cdc2 and cyclin are not immunoprecipitated by anti-PSTAIR antibodies; (iii) accumulation of unphosphorylated cyclin by aphidicolin treatment of the cells, triggers a dramatic accumulation of tyrosine-phosphorylated p34cdc2; and (iv) inhibition of cyclin synthesis by emetine inhibits p34cdc2 tyrosine phosphorylation without affecting the p34cdc2 concentration. These results show that, as it is synthesized, cyclin B binds and recruits p34cdc2 for tyrosine phosphorylation; this inactive complex then requires the completion of DNA replication before it can be turned into fully active MPF. These results fully confirm recent data obtained in vitro with exogenous cyclin added to cycloheximide-treated Xenopus egg extracts.
一种普遍存在的细胞内因子,即“M期促进因子”(MPF),在所有生物体中触发细胞周期的G2/M转换。在G2晚期,它以酪氨酸磷酸化的p34cdc2和未磷酸化的细胞周期蛋白Bcdc13的无活性复合物形式存在。在M期,其作为具有组蛋白H1激酶(H1K)活性的MPF的激活源于p34cdc2亚基的酪氨酸去磷酸化和细胞周期蛋白Bcdc13亚基的磷酸化同时发生。我们以高度同步化的有丝分裂海胆卵为模型,研究了细胞周期蛋白在该复合物形成以及p34cdc2酪氨酸磷酸化中的作用。当细胞离开S期进入G2期时,p34cdc2会发生大量酪氨酸磷酸化。这种p34cdc2酪氨酸磷酸化的大量爆发并非源于p34cdc2浓度的大幅增加。它似乎甚至只影响细胞中总p34cdc2的一部分(不能被抗PSTAIR抗体免疫沉淀)。一些观察结果表明未磷酸化的细胞周期蛋白的积累与p34cdc2酪氨酸磷酸化之间存在极其紧密的关联:(i)这两个事件在G2期完美重合;(ii)酪氨酸磷酸化的p34cdc2和细胞周期蛋白都不能被抗PSTAIR抗体免疫沉淀;(iii)用阿非迪霉素处理细胞使未磷酸化的细胞周期蛋白积累,会引发酪氨酸磷酸化的p34cdc2的大量积累;(iv)用放线菌酮抑制细胞周期蛋白合成会抑制p34cdc2酪氨酸磷酸化,而不影响p34cdc2的浓度。这些结果表明,细胞周期蛋白B在合成时会结合并募集p34cdc2进行酪氨酸磷酸化;这种无活性复合物在DNA复制完成之前需要完成,才能转变为完全活性的MPF。这些结果充分证实了最近在体外将外源细胞周期蛋白添加到用环己酰亚胺处理的非洲爪蟾卵提取物中获得的数据。